Ontrak (HY11) AI Stock Analysis
Ontrak
(Munich:HY11)
No summary available
Ontrak (HY11) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 708
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- 0.0
- Beta (1Y)
- ―
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- Germany
- Employees
- 104
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Healthcare Information Services
Ontrak Business Overview & Revenue Model
Company Description
Ontrak, Inc. is a virtualized healthcare company that leverages artificial intelligence and telehealth to deliver services, including in-person components, to health plans and other third-party payors across the United States. Its sophisticated, tech...
Ontrak Earnings Call Summary
The earnings call reflects a mixed sentiment with significant operational improvements and growth in membership contrasted by a notable decline in revenue and gross margin due to customer loss. While there are promising new business opportunities, the financial challenges remain a concern.
Q1-2025 Updates
Positive Updates
Negative Updates
Company Guidance
During the Ontrak Health First Quarter 2025 Earnings Conference Call, the company provided optimistic guidance regarding its future prospects. Ontrak anticipates doubling its run rate revenue in 2025 compared to 2024, driven by successful conversions of new customer opportunities, notably with a large Midwestern Medicaid plan. The company reported a significant increase in enrolled members, reaching 3,165 by the end of Q1, which nearly doubled year-over-year. The quarter's revenue was $2 million, reflecting a 25% decrease from the previous year, attributed to the loss of a customer at the end of 2024. However, the company expects Q2 2025 revenues to range from $2.2 million to $2.6 million, representing an 8% to 22% sequential increase. Ontrak's strategic investments in AI-driven technology and expanded solution offerings, including the Engage program, have significantly improved productivity and market reach, with the potential to address critical gaps in the behavioral health care landscape. The company also highlighted its strong pipeline of prospective contracts that could bring an additional $15 million in revenue, potentially doubling its current customer-based revenue.
Ontrak Risk Analysis
Ontrak disclosed 61 risk factors in its most recent earnings report. Ontrak reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
1 New RiskOntrak Peers Comparison
Overall Rating
BTSG72Outperform
HNGE69Neutral
OMDA67Neutral
EVH59Neutral
TDOC52Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| BTSG | 72Outperform | $13.24B | 40.79 | 16.75% | ― | 22.86% | 157.24% |
| HNGE | 69Neutral | $9.22B | 84.89 | 30.25% | ― | 49.76% | ― |
| OMDA | 67Neutral | $1.15B | 275.85 | 1.84% | ― | 47.63% | ― |
| EVH | 59Neutral | $486.16M | -0.96 | -99.16% | ― | -4.50% | -184.71% |
| TDOC | 52Neutral | $1.55B | -9.89 | -11.63% | ― | -2.38% | 32.73% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:HY11 | Ontrak, Inc. | 1.88 | 0.00 | 0.00% | |
| EVH | Evolent Health Inc. | 4.30 | -2.42 | -36.01% | |
| TDOC | Teladoc Inc. | 8.51 | 0.37 | 4.55% | |
| BTSG | BrightSpring Health Services, Inc. | 66.89 | 33.40 | 99.73% | |
| HNGE | Hinge Health, Inc. Class A | 114.32 | 63.98 | 127.10% | |
| OMDA | Omada Health, Inc. | 18.73 | -6.94 | -27.04% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.